Latest News Releases From The Newsroom
Buy Ratings: TARS, VICR, SNDX, ENLC, AMZN, UFPT, PEN - Key Upside Potential
June 26th, 2023
Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS), a biopharmaceutical company specializing in ophthalmic therapeutics, has been maintained at a Buy rating by HC Wainwright & Co., who raised the price target from $40 to $44. $TARS closed at $17.15. Read more
Biomea Fusion's Momentum; Aldeyra and Nkarta's Momentum Building
June 26th, 2023
Shares of Biomea Fusion, Inc. (Nasdaq: BMEA) surged to $32.87 during early trading on Monday, driven by positive clinical data from its Phase II study on BMF-219 in type 2 diabetes patients. However, by the end of the trading session, $BMEA closed at. Read more
Biden-Harris Admin's $40B+ Internet Initiative: Bridging the Digital Divide
June 26th, 2023
The Biden-Harris Administration has made a historic announcement, allocating over $40 billion to connect every American to affordable, reliable, high-speed internet. This marks the largest internet funding announcement in history and is part of the A. Read more
Breaking: Promising Sonelokimab's HS Trial Data Propels MoonLake Immunotherapeutics
June 26th, 2023
MoonLake Immunotherapeutics (Nasdaq: MLTX), a clinical-stage biotechnology company, announced positive results from its Phase 2 MIRA trial, evaluating the effectiveness and safety of the Nanobody sonelokimab, administered subcutaneously, in. Read more
Raymond James' View on ALK, LUV, DAL, UAL, and ALGT: Unveiling Potential Upsides
June 26th, 2023
Alaska Air Group, Inc. (NYSE: ALK), the parent company of Alaska Airlines and Horizon Air, has been maintained with a Strong Buy rating by Raymond James, who raised the price target from $70 to $75. Despite $ALK closing at $49.25 on Friday, the re. Read more
Pharvaris Gains Momentum, Avalo Therapeutics and FibroGen Suffer Setbacks
June 26th, 2023
Shares of Pharvaris N.V. (Nasdaq: PHVS) surged over 10% in pre-market trading after the clinical-stage company announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on its Investigational New Drug (IND) application f. Read more
EV Market Shakers: XPeng G6 Launch and Tesla's Downgrade
June 26th, 2023
XPeng Inc. (NYSE: XPEV), a leading Chinese electric vehicle manufacturer, is poised to have a significant impact on the automotive market with the highly anticipated launch of its XPENG G6 Ultra Smart Coupe SUV. This revolutionary vehicle, developed . Read more
Lucid and Lilium Make Waves: Lucid's Aston Martin Deal, Lilium's FAA Milestone
June 26th, 2023
Shares of Lucid Group, Inc. (Nasdaq: LCID) surged over 5% in pre-market trading after announcing a long-term strategic technology partnership with Aston Martin. The partnership involves the integration and supply of Lucid's advanced electric vehic. Read more
What's Expected: NIKE, McCormick, Acuity Brands, Nano Dimension - Earnings Preview
June 26th, 2023
Several companies are set to release their financial results on Thursday, June 29, including: NIKE, Inc. (NYSE: NKE), a global sports apparel and footwear giant, will unveil its fourth-quarter fiscal 2023 financial results after regular trading ho. Read more
US Coast Guard Launches Highest Level of Investigation into Titan Submersible Loss
June 25th, 2023
The U.S. Coast Guard said it has initiated a Marine Board of Investigation (MBI) following the tragic incident involving the Titan submersible and its five occupants. The crew of the Polar Prince research vessel lost communication with the Titan subm. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Earnings Countdown: Lockheed Martin, Stryker, and PACCAR Gear Up
January 26th, 2025Earnings Spotlight: SoFi Technologies, Sanmina, and Nucor Set to Report
January 26th, 2025Global Flag Football League Plans To Host Pro Flag Football Tournament in Las Vegas
January 23rd, 2025Earnings On Deck: Netflix, United Airlines, and Agilysys Gear Up
January 19th, 2025
Member Login